glp 1 is not working for me GLP-1 Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 Genetics: How Genes Affect

Low adoption of weight loss medications: a comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s

A comprehensive meta-analysis, including SOUL trial data, demonstrated that long-acting GLP-1 RAs reduce the incidence of major adverse cardiovascular events (MACEs), hospitalization for heart failure, kidney events, and all-cause mortality in type 2 diabetes [66]

111 Lifestyle management is integral throughout MASLD, with some perspectives advocating for initiation as long as metabolic risk factors are present

October 2, 2023

Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomised controlled trials